Press Releases

August 09, 2021
Rheos Medicines Appoints Nirupama Subramanian as Chief Operating Officer
July 12, 2021
Rheos Medicines Appoints Industry Leader, John Davis, Jr., M.D., M.P.H., M.S., to Board of Directors
May 27, 2021
Rheos Medicines to Present at Jefferies Virtual Healthcare Conference
December 17, 2020
Rheos Medicines and PatientsLikeMe Announce Strategic Collaboration to Investigate Underlying Metabolic Drivers of Immune-Mediated Disease
October 21, 2020
Rheos Medicines Appoints Dania Rabah, Ph.D., as Chief Scientific Officer
September 28, 2020
Rheos Medicines to Participate in Stifel 2020 Immunology and Inflammation Virtual Summit
February 18, 2020
Rheos Medicines to Present at the Cowen and Company 40^th Annual Health Care Conference
December 19, 2019
Rheos Medicines Announces Worldwide Collaboration with Roche to Discover and Develop Novel Medicines in the Field of Immunometabolism
December 12, 2019
Rheos Medicines Announces Publication of Perspective in Cell Metabolism Highlighting the Rationale and Potential of Employing Principles of Immunometabolism to Discover and Develop Novel Medicines
October 21, 2019
Rheos Medicines Appoints Barbara S. Fox as Chief Executive Officer
March 07, 2019
Rheos Medicines to Present at the Cowen and Company 39th Annual Health Care Conference
October 10, 2018
Rheos Medicines Expands Leadership Team with Appointments of Gad Soffer as Chief Operating Officer and J. Duncan Higgons to Board of Directors
March 22, 2018
Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases